Hanson & Doremus Investment Management’s Boston Scientific BSX Stock Holding History

Hanson & Doremus Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-75	Closed	-$7K	–	487
2025 Q3	$7K	Hold	75	–	–	﹤0.01%	455
2025 Q2	$8K	Hold	75	–	–	﹤0.01%	439
2025 Q1	$8K	Hold	75	–	–	﹤0.01%	432
2024 Q4	$7K	Buy	+75	New	+$6.6K	﹤0.01%	426
2023 Q3	–	Sell	-319	Closed	-$17K	–	426
2023 Q2	$17K	Buy	+319	New	+$16.7K	﹤0.01%	373
2022 Q1	–	Sell	-69	Closed	-$3K	–	514
2021 Q4	$3K	Hold	69	–	–	﹤0.01%	465
2021 Q3	$3K	Buy	+69	New	+$3.05K	﹤0.01%	455
2021 Q2	–	Sell	-69	Closed	-$3K	–	430
2021 Q1	$3K	Buy	+69	New	+$2.61K	﹤0.01%	461

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Hanson & Doremus Investment Management's BSX Position: Q4 2025 in Review

Hanson & Doremus Investment Management sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 75 shares — an estimated $7K sold.

Hanson & Doremus Investment Management first reported a position in BSX in Q1 2021 and held it in 8 quarters. The position peaked at $17K in Q2 2023. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Hanson & Doremus Investment Management reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Hanson & Doremus Investment Management sold 75 Boston Scientific shares in Q4 2025, an estimated $7K.
Hanson & Doremus Investment Management first reported a position in Boston Scientific in Q1 2021 and held it in 8 quarters.
Hanson & Doremus Investment Management's Boston Scientific position peaked at $17K in Q2 2023.
1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Hanson & Doremus Investment Management's 13F filing for Q4 2025, filed 20 Jan 2026.